Chieh‐Li Yen

596 total citations
44 papers, 383 citations indexed

About

Chieh‐Li Yen is a scholar working on Nephrology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Chieh‐Li Yen has authored 44 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 15 papers in Surgery and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Chieh‐Li Yen's work include Dialysis and Renal Disease Management (9 papers), Acute Kidney Injury Research (9 papers) and Lipoproteins and Cardiovascular Health (8 papers). Chieh‐Li Yen is often cited by papers focused on Dialysis and Renal Disease Management (9 papers), Acute Kidney Injury Research (9 papers) and Lipoproteins and Cardiovascular Health (8 papers). Chieh‐Li Yen collaborates with scholars based in Taiwan, United States and Italy. Chieh‐Li Yen's co-authors include Jia‐Jin Chen, Tao Han Lee, Pei‐Chun Fan, George Kuo, Cheng‐Chia Lee, Chih‐Hsiang Chang, Ya‐Chung Tian, Huang‐Yu Yang, Hsiang‐Hao Hsu and Chao‐Yu Chen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Nutrients.

In The Last Decade

Chieh‐Li Yen

43 papers receiving 376 citations

Peers

Chieh‐Li Yen
Chieh‐Li Yen
Citations per year, relative to Chieh‐Li Yen Chieh‐Li Yen (= 1×) peers Sheila Bermejo

Countries citing papers authored by Chieh‐Li Yen

Since Specialization
Citations

This map shows the geographic impact of Chieh‐Li Yen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chieh‐Li Yen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chieh‐Li Yen more than expected).

Fields of papers citing papers by Chieh‐Li Yen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chieh‐Li Yen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chieh‐Li Yen. The network helps show where Chieh‐Li Yen may publish in the future.

Co-authorship network of co-authors of Chieh‐Li Yen

This figure shows the co-authorship network connecting the top 25 collaborators of Chieh‐Li Yen. A scholar is included among the top collaborators of Chieh‐Li Yen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chieh‐Li Yen. Chieh‐Li Yen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Baojun, Chieh‐Li Yen, Chao‐Yi Wu, et al.. (2025). SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM. Scientific Reports. 15(1). 5872–5872. 4 indexed citations
3.
Chen, Jia‐Jin, Cheng‐Chia Lee, Chieh‐Li Yen, et al.. (2024). Impact of Different Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blocker Resumption Timing on Post Acute Kidney Injury Outcomes. Kidney International Reports. 9(11). 3290–3300. 1 indexed citations
4.
Chen, Jia-Jin, Ming‐Jen Chan, Pei‐Chun Fan, et al.. (2024). Non-recovery acute kidney injury and additional risk factors for short-term and long-term hypoglycemia: A multi-institutional cohort study. Journal of the Formosan Medical Association. 125(2). 147–154.
5.
Yen, Chieh‐Li, Pei‐Chun Fan, Cheng‐Chia Lee, et al.. (2024). Fibrate and the risk of cardiovascular disease among moderate chronic kidney disease patients with primary hypertriglyceridemia. Frontiers in Endocrinology. 15. 1333553–1333553. 3 indexed citations
6.
Fan, Pei‐Chun, et al.. (2023). Can Concurrent Fibrate Use Reduce Cardiovascular Risks among Moderate Chronic Kidney Disease Patients Undergoing Statin Therapy? A Cohort Study. Journal of Clinical Medicine. 13(1). 168–168. 1 indexed citations
7.
Chen, Jia‐Jin, Tao Han Lee, George Kuo, et al.. (2023). All-cause and immune checkpoint inhibitor–associated acute kidney injury in immune checkpoint inhibitor users: a meta-analysis of occurrence rate, risk factors and mortality. Clinical Kidney Journal. 17(1). sfad292–sfad292. 10 indexed citations
8.
Yen, Chieh‐Li, Pei‐Chun Fan, Jia‐Jin Chen, et al.. (2022). Ketoanalogues Supplemental Low Protein Diet Safely Decreases Short-Term Risk of Dialysis among CKD Stage 4 Patients. Nutrients. 14(19). 4020–4020. 8 indexed citations
9.
Tu, Kun‐Hua, Cheng‐Chia Lee, Pei‐Chun Fan, et al.. (2022). Supplementation with Folic Acid and Cardiovascular Outcomes in End-Stage Kidney Disease: A Multi-Institution Cohort Study. Nutrients. 14(19). 4162–4162. 3 indexed citations
10.
Lee, Cheng‐Chia, George Kuo, Ming‐Jen Chan, et al.. (2022). Characteristics of and Outcomes After Dialysis-Treated Acute Kidney Injury, 2009-2018: A Taiwanese Multicenter Study. American Journal of Kidney Diseases. 81(6). 665–674.e1. 8 indexed citations
11.
Yen, Chieh‐Li, Pei‐Chun Fan, Cheng‐Chia Lee, et al.. (2022). Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease. Journal of the American Heart Association. 11(19). 8–11. 11 indexed citations
12.
Chang, Chih‐Hsiang, Shao‐Wei Chen, Jia‐Jin Chen, et al.. (2021). Incidence and Transition of Acute Kidney Injury, Acute Kidney Disease to Chronic Kidney Disease after Acute Type A Aortic Dissection Surgery. Journal of Clinical Medicine. 10(20). 4769–4769. 19 indexed citations
13.
Yen, Chieh‐Li, Pei‐Chun Fan, George Kuo, et al.. (2021). Supplemented Low-Protein Diet May Delay the Need for Preemptive Kidney Transplantation: A Nationwide Population-Based Cohort Study. Nutrients. 13(9). 3002–3002. 2 indexed citations
14.
Chen, Jia‐Jin, Tao Han Lee, Yu‐Kang Tu, et al.. (2021). Pharmacological and non-pharmacological treatments for restless legs syndrome in end-stage kidney disease: a systematic review and component network meta-analysis. Nephrology Dialysis Transplantation. 37(10). 1982–1992. 14 indexed citations
15.
Yen, Chieh‐Li, Pei‐Chun Fan, George Kuo, et al.. (2021). Prognostic Performance of Existing Scoring Systems among Critically Ill Patients Requiring Continuous Renal Replacement Therapy: An Observational Study. Journal of Clinical Medicine. 10(19). 4592–4592. 3 indexed citations
16.
Kuo, George, Chieh‐Li Yen, Yueh-An Lu, et al.. (2021). Clinical and visual outcomes following endogenous endophthalmitis: 175 consecutive cases from a tertiary referral center in Taiwan. Journal of Microbiology Immunology and Infection. 55(1). 114–122. 13 indexed citations
17.
Lee, Tao Han, Cheng‐Chia Lee, Jia‐Jin Chen, et al.. (2021). Assessment of Cardiopulmonary Bypass Duration Improves Novel Biomarker Detection for Predicting Postoperative Acute Kidney Injury after Cardiovascular Surgery. Journal of Clinical Medicine. 10(13). 2741–2741. 6 indexed citations
18.
Chen, Jia‐Jin, George Kuo, Pei‐Chun Fan, et al.. (2021). Neutrophil-to-lymphocyte ratio is a marker for acute kidney injury progression and mortality in critically ill populations: a population-based, multi-institutional study. Journal of Nephrology. 35(3). 911–920. 22 indexed citations
19.
Yen, Chieh‐Li, Pei‐Chun Fan, Cheng‐Chia Lee, et al.. (2020). Advanced Chronic Kidney Disease with Low and Very Low GFR: Can a Low-Protein Diet Supplemented with Ketoanalogues Delay Dialysis?. Nutrients. 12(11). 3358–3358. 9 indexed citations
20.
Yen, Chieh‐Li, Ya‐Chung Tian, Hsin‐Hsu Wu, et al.. (2016). Conversion to mTOR-inhibitors with calcineurin inhibitor elimination or minimization reduces urinary polyomavirus BK load in kidney transplant recipients. Journal of the Formosan Medical Association. 115(7). 539–546. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026